195 related articles for article (PubMed ID: 36634606)
41. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.
Gupta S; Provenzale D; Regenbogen SE; Hampel H; Slavin TP; Hall MJ; Llor X; Chung DC; Ahnen DJ; Bray T; Cooper G; Early DS; Ford JM; Giardiello FM; Grady W; Halverson AL; Hamilton SR; Klapman JB; Larson DW; Lazenby AJ; Lynch PM; Markowitz AJ; Mayer RJ; Ness RM; Samadder NJ; Shike M; Sugandha S; Weiss JM; Dwyer MA; Ogba N
J Natl Compr Canc Netw; 2017 Dec; 15(12):1465-1475. PubMed ID: 29223984
[TBL] [Abstract][Full Text] [Related]
42. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.
Tabouret E; Nguyen AT; Dehais C; Carpentier C; Ducray F; Idbaih A; Mokhtari K; Jouvet A; Uro-Coste E; Colin C; Chinot O; Loiseau H; Moyal E; Maurage CA; Polivka M; Lechapt-Zalcman E; Desenclos C; Meyronet D; Delattre JY; Figarella-Branger D;
Acta Neuropathol; 2016 Oct; 132(4):625-34. PubMed ID: 27573687
[TBL] [Abstract][Full Text] [Related]
43. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
[TBL] [Abstract][Full Text] [Related]
44. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
[TBL] [Abstract][Full Text] [Related]
45. Adolescents and Young Adults With Cancer: CNS Tumors.
Wu J; Heidelberg RE; Gajjar A
J Clin Oncol; 2024 Feb; 42(6):686-695. PubMed ID: 38064656
[TBL] [Abstract][Full Text] [Related]
46. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
Bale TA; Rosenblum MK
Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
[TBL] [Abstract][Full Text] [Related]
47. [Update on the 2016 WHO classification of tumors of the central nervous system - Part 1: Diffusely infiltrating gliomas].
Švajdler M; Rychlý B; Zámečník J; Švajdler P
Cesk Patol; 2017; 53(1):12-21. PubMed ID: 28248117
[TBL] [Abstract][Full Text] [Related]
48. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
Malzkorn B; Reifenberger G
Pathologe; 2019 Jun; 40(Suppl 1):9-17. PubMed ID: 31025086
[TBL] [Abstract][Full Text] [Related]
49. CNS Tumors - clinical and radiological aspects.
Emmerová R; Engelová J; Vinakurau S; Ondrová B
Cesk Patol; 2022; 58(3):150-160. PubMed ID: 36224037
[TBL] [Abstract][Full Text] [Related]
50. Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?
Weller M; Reifenberger G
Curr Opin Neurol; 2020 Dec; 33(6):701-706. PubMed ID: 33177376
[TBL] [Abstract][Full Text] [Related]
51. Brain Metastases and Leptomeningeal Disease.
Kumthekar P; Le Rhun E
Continuum (Minneap Minn); 2023 Dec; 29(6):1727-1751. PubMed ID: 38085896
[TBL] [Abstract][Full Text] [Related]
52. Major Features of the 2021 WHO Classification of CNS Tumors.
Smith HL; Wadhwani N; Horbinski C
Neurotherapeutics; 2022 Oct; 19(6):1691-1704. PubMed ID: 35578106
[TBL] [Abstract][Full Text] [Related]
53. Diffuse Infiltrating Oligodendroglioma and Astrocytoma.
van den Bent MJ; Smits M; Kros JM; Chang SM
J Clin Oncol; 2017 Jul; 35(21):2394-2401. PubMed ID: 28640702
[TBL] [Abstract][Full Text] [Related]
54. Germ cell tumors with neuroglial differentiation do not show molecular features akin to their central nervous system counterpart: experience from extra-gynecological sites.
Chatterjee D; Gude G; Samujh R; Mete UK; Radotra B
Virchows Arch; 2022 Aug; 481(2):213-221. PubMed ID: 35678876
[TBL] [Abstract][Full Text] [Related]
55. NCCN Guidelines® Insights: Palliative Care, Version 2.2021.
Dans M; Kutner JS; Agarwal R; Baker JN; Bauman JR; Beck AC; Campbell TC; Carey EC; Case AA; Dalal S; Doberman DJ; Epstein AS; Fecher L; Jones J; Kapo J; Lee RT; Loggers ET; McCammon S; Mitchell W; Ogunseitan AB; Portman DG; Ramchandran K; Sutton L; Temel J; Teply ML; Terauchi SY; Thomas J; Walling AM; Zachariah F; Bergman MA; Ogba N; Campbell M
J Natl Compr Canc Netw; 2021 Jul; 19(7):780-788. PubMed ID: 34340208
[TBL] [Abstract][Full Text] [Related]
56. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.
Adelstein D; Gillison ML; Pfister DG; Spencer S; Adkins D; Brizel DM; Burtness B; Busse PM; Caudell JJ; Cmelak AJ; Colevas AD; Eisele DW; Fenton M; Foote RL; Gilbert J; Haddad RI; Hicks WL; Hitchcock YJ; Jimeno A; Leizman D; Lydiatt WM; Maghami E; Mell LK; Mittal BB; Pinto HA; Ridge JA; Rocco J; Rodriguez CP; Shah JP; Weber RS; Witek M; Worden F; Yom SS; Zhen W; Burns JL; Darlow SD
J Natl Compr Canc Netw; 2017 Jun; 15(6):761-770. PubMed ID: 28596256
[TBL] [Abstract][Full Text] [Related]
57. Glioblastoma: Changing concepts in the WHO CNS5 classification.
Chen J; Han P; Dahiya S
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S24-S32. PubMed ID: 35562131
[TBL] [Abstract][Full Text] [Related]
58. SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021).
Martínez-García M; Servitja Tormo S; Vilariño Quintela N; Arance Fernández A; Berrocal Jaime A; Cantos Sánchez de Ibargüen B; Del Barco Berrón S; García Campelo R; Gironés Sarrió R; Manuel Sepúlveda-Sánchez J
Clin Transl Oncol; 2022 Apr; 24(4):703-711. PubMed ID: 35258806
[TBL] [Abstract][Full Text] [Related]
59. NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017.
Nabors LB; Portnow J; Ammirati M; Baehring J; Brem H; Butowski N; Fenstermaker RA; Forsyth P; Hattangadi-Gluth J; Holdhoff M; Howard S; Junck L; Kaley T; Kumthekar P; Loeffler JS; Moots PL; Mrugala MM; Nagpal S; Pandey M; Parney I; Peters K; Puduvalli VK; Ragsdale J; Rockhill J; Rogers L; Rusthoven C; Shonka N; Shrieve DC; Sills AK; Swinnen LJ; Tsien C; Weiss S; Wen PY; Willmarth N; Bergman MA; Engh A
J Natl Compr Canc Netw; 2017 Nov; 15(11):1331-1345. PubMed ID: 29118226
[TBL] [Abstract][Full Text] [Related]
60. Extent of Resection of Glioblastoma: A Critical Evaluation in the Molecular Era.
Cahill DP
Neurosurg Clin N Am; 2021 Jan; 32(1):23-29. PubMed ID: 33223023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
